Findings from the final overall survival and updated safety analysis of the INTRIGUE study
Home World News Similar Median OS Between Ripretinib versus Sunitinib in Patients with Advanced GIST...
Findings from the final overall survival and updated safety analysis of the INTRIGUE study
